EMTC

Elbit Medical Technologies Ltd Stock Price

TASE:EMTC-M Community·₪17.1m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

EMTC-M Share Price Performance

₪0.19
-0.05 (-19.31%)
₪0.19
-0.05 (-19.31%)
Price ₪0.19

EMTC-M Community Narratives

There are no narratives available yet.

Snowflake Analysis

Flawless balance sheet with moderate risk.

5 Risks
2 Rewards

Elbit Medical Technologies Ltd Key Details

US$0

Revenue

US$0

Cost of Revenue

US$0

Gross Profit

-US$276.0k

Other Expenses

US$276.0k

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
0.003
0%
0%
0%
View Full Analysis

About EMTC-M

Founded
n/a
Employees
412
CEO
Ron Hadassi
Website
n/a

Elbit Medical Technologies Ltd, an investment holding company, engages in the research, development, production, and marketing of therapeutic medical systems in the United States, Europe, and internationally. The company is developing a magnetic resonance imaging guided focused ultrasound treatment equipment to address various oncology and gynecology indications, as well as neurological disorders and tumors. It is also involved in the study and development of medical products based on stem cells originating primarily from the umbilical cord blood that are used for bone marrow transplants in the patients of leukemia or cancer of lymph nodes, non-malignant blood diseases, and metabolic genetic disorders. The company is based in Petah Tikva, Israel. Elbit Medical Technologies Ltd is a subsidiary of Exigent Management Ltd.

Recent EMTC-M News & Updates

Recent updates

No updates